1. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma;Spence;Am. J. Respir. Crit. Care Med.,1994
2. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice;Leusch;Eur. J. Pharm. Sci.,2002
3. Species differences in PAF receptor binding in the lungs between hamster and guinea pig;Chen;J. Lipid Mediat. Cell Signal.,1997
4. Inverse agonist activity of selected ligands of platelet-activating factor receptor;Dupre;J. Pharmacol. Exp. Ther.,2001
5. Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man;Brecht;Arzneimittelforschung,1991